Bladder Cancer. Two words that carry a devastating impact. Every year, over 570,000 people are diagnosed with bladder cancer globally, and for many, it is the first time they hear about it. We are committed to change this. Let’s bring awareness to the symptoms to watch out for and encourage acting on them without delay. Early diagnosis is crucial to increasing the chance of long-term survival and improving quality of life.
Bladder Cancer Awareness Month 2023 campaign
We are thrilled to announce our new,
This World Cancer Day, the World Bladder Cancer Patient Coalition is proud to join the international cancer community efforts. Jointly, we advocate for greater access to care for marginalised populations and closing the gap in cancer care worldwide.
World Cancer Day takes place every year on February 4 and is the uniting global initiative under which the world comes together to raise the profile of cancer in a positive and inspiring way. Spearheaded by the Union for International Cancer Control (UICC),
In collaboration with Cancer Vessie France, our member organisation in France, we developed a new infographic titled “Stigma: The Invisible side of bladder cancer”. This infographic highlights the impact of stigma on bladder cancer patients based on data from 312 patients and caregivers, including 38 from France, who shared their experiences through surveys and qualitative interviews
The themes explored in the infographic include:
- The disease disadvantages
- The experience of internal stigma
- The experience of external stigma
The research was conducted to gain a deeper understanding of the impact of bladder cancer on patients and caregivers and to explore the existence,
On the occasion of World Cancer Day on February 4, 2022, the World Bladder Cancer Patient Coalition (WBCPC) is proud to join forces with the international cancer community to raise awareness.
World Cancer Day 2023 marks the second year of the three-year ‘Close the care gap’ campaign centered on the issue of equity. This second year is about uniting individuals and organisations, advocates and policymakers in calling for change and taking action.
In this video, the World Bladder Cancer Patient Coalition team wishes the bladder cancer community a happy and healthy New Year and shares their exciting plans and priorities for 2023.
We highlight many different projects that will take place this year:
- The release of our Global Bladder Cancer Patient Survey report will guide and inform the future work of WBCPC, our member organisations, and our partners in countries around the world.
Together with our member organisation in the United Kingdom – Fight Bladder Cancer, we developed a new infographic Stigma: The Invisible side of bladder cancer – When it comes to stigma, bladder cancer patients reported primarily worrying about disease disadvantage, self-stigma, and external stigma. The infographic features data from 312 patients and caregivers of which 69 are from the United Kingdom and have shared their experiences in a survey and qualitative interviews.
The Workgroup of European Cancer Patient Advocacy Networks (WECAN) serves as a platform for cancer patient organisations to collaborate, learn, and align to strengthen European patient advocacy. WECAN now brings together over 20 umbrella cancer patient advocacy organisations active in Europe. The World Bladder Cancer Patient Coalition has been a committed member of WECAN since 2020.
WECAN has recently launched its 2022 Activity Report. In the report, you will learn about WECAN’s achievements last year and the collective efforts of the community to strengthen cancer patient advocacy.
Stigma: The Invisible side of bladder cancer – This infographic aims to highlight the impact of stigma on people affected by bladder cancer based on shared lived experiences from patients and caregivers.
When it comes to stigma, bladder cancer patients reported primarily worrying about disease disadvantage, self-stigma, and external stigma. The infographic, originally published in September 2022, features data from 312 patients and caregivers from France, Spain, Germany, the United Kingdom and the United States of America.
